Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biocept Inc (NQ: BIOC )

5.360 USD -0.120 (-2.19%)
Official Closing Price Updated: 7:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Biocept Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Biocept Issues Letter to Stockholders
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular testing to provide physicians with clinically actionable information to improve patient outcomes, announces that President and... 
From Business Wire News Releases
Biocept to Present at H.C. Wainwright Virtual BioConnect Conference
CEO Michael Nall to participate in diagnostics and devices panel discussion hosted by former FDA Commissioner Dr. Scott Gottlieb 
From PR Newswire
Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve... 
From PR Newswire
Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations
Expands physician and patient access to Biocept's Target Selector™ liquid biopsy testing for the management of patients diagnosed with cancer 
From PR Newswire
My “Trade Ideas Special” edition for the last week of 2020
Tags GLG CEI BIOC
From AC Investor Blog
Biocept Provides Business Update
Announces receipt of more than 150,000 samples for COVID-19 testing and completes relocation to new facility 
From PR Newswire
84 Biggest Movers From Yesterday
Gainers SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) shares climbed 176.4% to close at $17.66 on Thursday after climbing 73% on ... 
Tags PRLD TTGT AQB
From Benzinga
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner,EOC Pharma ... 
Tags Mid/Day Movers XBIO UAN
From Benzinga
Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center
Using Target Selector™ to detect HER2 alterations assists physicians in reassessing therapy options over the course of treating patients with metastatic breast cancer 
From PR Newswire
While The U.S. Faces Insufficient COVID-19 Testing Volume, EIR Healthcare Launches MedModLabs to Expand Access Immediately
Healthcare design innovation firm known for its 'hospital in a box' solution expands modular offerings with new MedModLabs initiative, first rolling out in Philadelphia to help address Pennsylvania's... 
From PR Newswire
Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central N
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve... 
From PR Newswire
Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve... 
From PR Newswire
65 Biggest Movers From Friday
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) shares jumped 93.5% to close at $16.02 on Friday after the company late Thursday ... 
Tags Trading Ideas AWX FTCH
From Benzinga
12 Healthcare Stocks Moving In Friday's Intraday Session
Gainers Urovant Sciences (NASDAQ:UROV) stock rose 93.47% to $16.02 during Friday's regular session. Trading volume ... 
Tags NMTR ARPO SAVA
From Benzinga
12 Healthcare Stocks Moving In Friday's Pre-Market Session
Gainers Urovant Sciences (NASDAQ:UROV) shares moved upwards by 92.87% to $15.97 during Friday's pre-market session. ... 
Tags MITO healthcare stocks IMAC
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SNY OPNT Penny Stocks
From Benzinga
46 Stocks Moving in Friday's Pre-Market Session
Gainers Urovant Sciences Ltd. (NASDAQ: UROV) rose 87% to $15.48 in pre-market trading. Sumitovant Biopharma will acquire Urovant ... 
Tags Pre/Market Outlook FTCH BIOC
From Benzinga
65 Biggest Movers From Yesterday
Gainers IMAC Holdings, Inc. (NASDAQ: IMAC) shares climbed 83.3% to close at $1.52 on Thursday after the company reported the ... 
Tags FOSL SINO GRWG
From Benzinga
13 Stocks Moving In Thursday's After-Hours Session
Gainers Cisco Systems (NASDAQ: CSCO)shares are trading higher after the company reported better-than-expected Q1 EPS and ... 
Tags DIS Movers Penny Stocks
From Benzinga
Biocept Reports Third Quarter 2020 Financial Results
Revenues of $6.6 million - a result of decision to offer COVID-19 testing 
From PR Newswire
Thinking about buying stock in IMAC Holdings, Advanced Micro Devices, Biocept, Li Auto, or EuroDry?
InvestorsObserver issues critical PriceWatch Alerts for IMAC, AMD, BIOC, LI, and EDRY. 
From PR Newswire
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning trading, 54 companies set new 52-week highs. Key Facts: ASML Holding (NASDAQ: ASML) was ... 
Tags CRC SHYF NVEE
From Benzinga
Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its COVID-19 testing with... 
From PR Newswire
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags DARE APTX ETON
From Benzinga
Earnings Scheduled For November 12, 2020
Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 ... 
Tags TNK DUOT LMPX
From Benzinga
Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells
Further expands global patent estate for capturing and detecting rare cells of interest, including CTCs, to aid in the treatment of patients with cancer 
From PR Newswire
Biocept Awarded Broad Japanese Patent for the Use of Binding Entities in Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any Sample Type
Biocept further expands its patent estate for capturing and detecting target cells of interest, including CTCs 
From PR Newswire
Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients, announces that it will release financial results for the... 
From PR Newswire
Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer, announces an update on its COVID-19 testing with... 
From PR Newswire
Biocept Appoints Samuel D. Riccitelli to its Board of Directors
Diagnostic industry veteran plans immediate start 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.